Search for: "PHARMASCIENCE INC" Results 1 - 14 of 14
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Jun 2021, 2:39 pm by Lawrence B. Ebert
Exela PharmaSci Inc., 780 F.3d 1364, 1372 (Fed. [read post]
11 Feb 2013, 3:04 pm
 From our much-admired former guest Kat and respected blogger Norman Siebrasse comes news that the IPKat has been judicially cited by Hughes J of the Federal Court of Canada in Pfizer Canada Inc v Pharmascience Inc 2013 FC 120 at paragraph 75, for the Kat's explanation of the "Angora cat" approach to claim construction (the cited url is not exactly right -- it says "com-uk" rather than "co.uk"). [read post]
27 Jan 2010, 3:00 am
- ‘indirect consumer tax’ to fund UN public health initiatives (Afro-IP) Canada: Submissions on Canada-EU trade deal: Canadian Generic Pharma Assoc. wants IP out (Michael Geist) Canada: Intellectual property and agriculture – CDC Triffid seed story (ipblog.ca) EU: Records of the 1st, 2nd and 3rd expert meetings on SPCs (The SPC Blog) EU: Cooperation between Board of Appeal and National Court / acceleration of appeal proceedings: Human Genome Sciences v Eli Lilly (EPLAW) Indian… [read post]
18 Sep 2013, 7:28 am
 The IPKat has stumbled across a decision earlier this year from the Federal Court, Canada, in Pfizer Canada Inc. v Pharmascience Inc. 2013 FC 120, dating back to 4 February. [read post]
22 Jan 2013, 10:35 pm by Andrew Langille
For case law in this area take a peek at the following decisions: Pharmascience Inc. v. [read post]
5 Aug 2009, 5:35 am
. - Patent Docs) US: America’s Affordable Health Choices Act : House Energy & Commerce Committee OKs 12-year data exclusivity for biotech drugs (Patent Baristas) (Patent Docs) (FDA Law Blog) (PatentlyBIOtech) (GenericsWeb) US: Patents and data exclusivity: It ain’t necessarily so (Patent Docs) US: Teva fights for biotech generics (GenericsWeb) US bill considers access to Canadian pharmaceuticals (Pharmacapsules@Gowlings) US: Bilski and biotechnology – an update… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
8 Jul 2009, 7:04 am
– CAFC decision in Agilent Techs v Affymetrix concerning claims pertaining to ‘microarray hybridization’ (Gray on Claims) US: Counterclaims dismissed in Alzheimer’s Institute/ Mayo patent licensing dispute over transgenic mice (Patent Docs)   Products (Tavanic) Levofloxacin – UK: EWCA upholds decision that Daiichi’s Levofloxacin patent and SPC both invalid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd and Daiichi Sankyo Co Ltd… [read post]
11 Jul 2008, 4:30 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
9 Aug 2008, 1:50 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners: PharmaStem … [read post]
30 May 2008, 9:09 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]